1. Home
  2. JYNT vs CBUS Comparison

JYNT vs CBUS Comparison

Compare JYNT & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • CBUS
  • Stock Information
  • Founded
  • JYNT 2010
  • CBUS 2010
  • Country
  • JYNT United States
  • CBUS United States
  • Employees
  • JYNT N/A
  • CBUS N/A
  • Industry
  • JYNT Multi-Sector Companies
  • CBUS Agricultural Chemicals
  • Sector
  • JYNT Miscellaneous
  • CBUS Industrials
  • Exchange
  • JYNT Nasdaq
  • CBUS Nasdaq
  • Market Cap
  • JYNT 170.3M
  • CBUS 72.0M
  • IPO Year
  • JYNT 2014
  • CBUS 2017
  • Fundamental
  • Price
  • JYNT $10.02
  • CBUS $1.33
  • Analyst Decision
  • JYNT Strong Buy
  • CBUS Strong Buy
  • Analyst Count
  • JYNT 3
  • CBUS 3
  • Target Price
  • JYNT $16.33
  • CBUS $22.00
  • AVG Volume (30 Days)
  • JYNT 82.6K
  • CBUS 197.4K
  • Earning Date
  • JYNT 11-06-2025
  • CBUS 11-06-2025
  • Dividend Yield
  • JYNT N/A
  • CBUS N/A
  • EPS Growth
  • JYNT N/A
  • CBUS N/A
  • EPS
  • JYNT N/A
  • CBUS N/A
  • Revenue
  • JYNT $53,449,713.00
  • CBUS $4,846,000.00
  • Revenue This Year
  • JYNT $8.06
  • CBUS $17.67
  • Revenue Next Year
  • JYNT $11.18
  • CBUS $63.43
  • P/E Ratio
  • JYNT N/A
  • CBUS N/A
  • Revenue Growth
  • JYNT 277.36
  • CBUS 63.66
  • 52 Week Low
  • JYNT $9.58
  • CBUS $1.20
  • 52 Week High
  • JYNT $13.47
  • CBUS $6.10
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 32.25
  • CBUS 44.66
  • Support Level
  • JYNT $9.85
  • CBUS $1.32
  • Resistance Level
  • JYNT $10.74
  • CBUS $1.41
  • Average True Range (ATR)
  • JYNT 0.20
  • CBUS 0.08
  • MACD
  • JYNT -0.05
  • CBUS 0.01
  • Stochastic Oscillator
  • JYNT 18.68
  • CBUS 40.00

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: